Microcella aerolata GA224 exhibits preventive potential against Streptococcus pneumoniae infection via the gut-lung axis.

IF 4 3区 生物学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Ningqianzi Tang, Yimin Pan, Zicheng Jin, Guoxia Zhang
{"title":"Microcella aerolata GA224 exhibits preventive potential against Streptococcus pneumoniae infection via the gut-lung axis.","authors":"Ningqianzi Tang, Yimin Pan, Zicheng Jin, Guoxia Zhang","doi":"10.1007/s11274-025-04478-5","DOIUrl":null,"url":null,"abstract":"<p><p>Antibiotics and vaccines have long been major key interventions against Streptococcus pneumoniae (Spn) infection. However, alternative therapies are urgently needed with the original therapies becoming suboptimal efficacy. A beneficial bacterium, Microcella aerolata strain GA224, with protective potential against Spn infection was isolated in previous study. Here, this protective effect was investigated at the bacterial, cellular and animal levels, exploring the mechanisms from the perspective of the gut-lung axis. Cellular and animal models of Spn infection were established and GA224 was administered for prevention or treatment. Spn adherence, inflammatory gene expression, histopathological features, gut microbial profiles and fecal metabolomic signatures were examined. In vitro, GA224 inhibited Spn growth with a bacteriostatic diameter of 16 mm and reduced adherence by 83.4% (P < 0.01) in prevention groups, while suppressing inflammatory gene expression (IL-1β, IL-6, TNF-α) by 40-50% (P < 0.001) in Spn-infected cells. In Spn-infected rats, GA224 intranasal administration improved body weight gain by 8.2% (vs. Tre group + 3.7%, P < 0.05) and reduced lung injury score by 25% (P < 0.01). In addition, GA224 administration alleviated dysbiosis of the gut microbiota, including declined abundance of Ruminiclostridium and Roseburia, increased abundance of Ruminococcus and restricted out-migration of infectious bacteria. In terms of the fecal metabolism, differential metabolites and disordered metabolic pathways were altered by GA224, including glycine, serine and threonine metabolism and pentose and glucuronate interconversion. Intestinal bacteria showed multiple correlations with fecal metabolites with strongest correlation founding between Ruminococcus and oxidized phospholipids. Notably, Anaerotaenia (r = -0.67 with LysoPC), Ruminiclostridium (positively correlated with lung coefficient, r = 0.62) and Ruminococcus (strongest correlation with oxidized phospholipids, r = 0.8) demonstrated microbiota-metabolite interactions potentially mediating gut-lung axis regulation.Finally, we demonstrate that M. aerolata GA224 provided a protective potential against Spn infection. In addition to the inhibition in adherence and inflammation, remodeling gut microbiota and improving metabolism via the gut-lung axis may be the critical avenue to this protective effect.</p>","PeriodicalId":23703,"journal":{"name":"World journal of microbiology & biotechnology","volume":"41 7","pages":"259"},"PeriodicalIF":4.0000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of microbiology & biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s11274-025-04478-5","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Antibiotics and vaccines have long been major key interventions against Streptococcus pneumoniae (Spn) infection. However, alternative therapies are urgently needed with the original therapies becoming suboptimal efficacy. A beneficial bacterium, Microcella aerolata strain GA224, with protective potential against Spn infection was isolated in previous study. Here, this protective effect was investigated at the bacterial, cellular and animal levels, exploring the mechanisms from the perspective of the gut-lung axis. Cellular and animal models of Spn infection were established and GA224 was administered for prevention or treatment. Spn adherence, inflammatory gene expression, histopathological features, gut microbial profiles and fecal metabolomic signatures were examined. In vitro, GA224 inhibited Spn growth with a bacteriostatic diameter of 16 mm and reduced adherence by 83.4% (P < 0.01) in prevention groups, while suppressing inflammatory gene expression (IL-1β, IL-6, TNF-α) by 40-50% (P < 0.001) in Spn-infected cells. In Spn-infected rats, GA224 intranasal administration improved body weight gain by 8.2% (vs. Tre group + 3.7%, P < 0.05) and reduced lung injury score by 25% (P < 0.01). In addition, GA224 administration alleviated dysbiosis of the gut microbiota, including declined abundance of Ruminiclostridium and Roseburia, increased abundance of Ruminococcus and restricted out-migration of infectious bacteria. In terms of the fecal metabolism, differential metabolites and disordered metabolic pathways were altered by GA224, including glycine, serine and threonine metabolism and pentose and glucuronate interconversion. Intestinal bacteria showed multiple correlations with fecal metabolites with strongest correlation founding between Ruminococcus and oxidized phospholipids. Notably, Anaerotaenia (r = -0.67 with LysoPC), Ruminiclostridium (positively correlated with lung coefficient, r = 0.62) and Ruminococcus (strongest correlation with oxidized phospholipids, r = 0.8) demonstrated microbiota-metabolite interactions potentially mediating gut-lung axis regulation.Finally, we demonstrate that M. aerolata GA224 provided a protective potential against Spn infection. In addition to the inhibition in adherence and inflammation, remodeling gut microbiota and improving metabolism via the gut-lung axis may be the critical avenue to this protective effect.

微胞菌GA224通过肠-肺轴对肺炎链球菌感染具有预防作用。
长期以来,抗生素和疫苗一直是防治肺炎链球菌感染的主要关键干预措施。然而,由于原有治疗方法的疗效不佳,迫切需要替代治疗方法。在前人的研究中,分离到了一株对Spn感染具有保护作用的有益菌——小微cella aerolata GA224。本研究从细菌、细胞和动物水平研究了这种保护作用,并从肠-肺轴的角度探讨了其机制。建立Spn感染的细胞和动物模型,并给予GA224预防或治疗。检查了Spn粘附、炎症基因表达、组织病理学特征、肠道微生物谱和粪便代谢组学特征。在体外,GA224抑制Spn生长,抑菌直径为16 mm,粘附率降低83.4% (P
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
World journal of microbiology & biotechnology
World journal of microbiology & biotechnology 工程技术-生物工程与应用微生物
CiteScore
6.30
自引率
2.40%
发文量
257
审稿时长
2.5 months
期刊介绍: World Journal of Microbiology and Biotechnology publishes research papers and review articles on all aspects of Microbiology and Microbial Biotechnology. Since its foundation, the Journal has provided a forum for research work directed toward finding microbiological and biotechnological solutions to global problems. As many of these problems, including crop productivity, public health and waste management, have major impacts in the developing world, the Journal especially reports on advances for and from developing regions. Some topics are not within the scope of the Journal. Please do not submit your manuscript if it falls into one of the following categories: · Virology · Simple isolation of microbes from local sources · Simple descriptions of an environment or reports on a procedure · Veterinary, agricultural and clinical topics in which the main focus is not on a microorganism · Data reporting on host response to microbes · Optimization of a procedure · Description of the biological effects of not fully identified compounds or undefined extracts of natural origin · Data on not fully purified enzymes or procedures in which they are applied All articles published in the Journal are independently refereed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信